Cargando…

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models

BACKGROUND: Adeno-associated virus (AAV) gene therapy vectors have shown the best outcomes in human clinical studies for the treatment of genetic diseases such as hemophilia. However, these pivotal investigations have also identified several challenges. For example, high vector doses are often used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markusic, David M., Nichols, Timothy C., Merricks, Elizabeth P., Palaschak, Brett, Zolotukhin, Irene, Marsic, Damien, Zolotukhin, Sergei, Srivastava, Arun, Herzog, Roland W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412045/ https://www.ncbi.nlm.nih.gov/pubmed/28460646 http://dx.doi.org/10.1186/s12967-017-1200-1

Ejemplares similares

An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8(+) T Cells
por: Palaschak, Brett, et al.
Publicado: (2017)

Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016)

Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
por: Kumar, Sandeep R.P., et al.
Publicado: (2021)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
por: Rogers, Geoffrey L, et al.
Publicado: (2014)

Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
por: Biswas, Moanaro, et al.
Publicado: (2020)

High-accuracy biodistribution analysis of adeno-associated virus variants by double barcode sequencing
por: Marsic, Damien, et al.
Publicado: (2015)

Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
por: Kondratov, Oleksandr, et al.
Publicado: (2023)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
por: Chan, Christopher, et al.
Publicado: (2023)

Removal of Endotoxin from rAAV Samples Using a Simple Detergent-Based Protocol
por: Kondratova, Liudmyla, et al.
Publicado: (2019)

Dynamics of antigen presentation to transgene product-specific CD4(+) T cells and of Treg induction upon hepatic AAV gene transfer
por: Perrin, George Q, et al.
Publicado: (2016)

B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin
por: Biswas, Moanaro, et al.
Publicado: (2020)

Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation
por: Crosson, Sean M., et al.
Publicado: (2018)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries
por: Marques, Andrew D., et al.
Publicado: (2020)

Effect of CpG Depletion of Vector Genome on CD8(+) T Cell Responses in AAV Gene Therapy
por: Bertolini, Thais B., et al.
Publicado: (2021)

Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog
por: Shao, Wenwei, et al.
Publicado: (2022)

Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
por: Martino, Ashley T., et al.
Publicado: (2009)

Distribution of Y-Receptors in Murine Lingual Epithelia
por: Hurtado, Maria D., et al.
Publicado: (2012)

Achieving High-Yield Production of Functional AAV5 Gene Delivery Vectors via Fedbatch in an Insect Cell-One Baculovirus System
por: Joshi, Pranav R.H., et al.
Publicado: (2019)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism
por: Mulcrone, Patrick L., et al.
Publicado: (2023)

Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
por: Pipe, Steven, et al.
Publicado: (2019)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies
por: Markusic, David M, et al.
Publicado: (2013)

Enhanced Factor IX Activity following Administration of AAV5-R338L “Padua” Factor IX versus AAV5 WT Human Factor IX in NHPs
por: Spronck, Elisabeth A., et al.
Publicado: (2019)

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
por: Mowat, FM, et al.
Publicado: (2013)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors
por: Ran, Gai, et al.
Publicado: (2020)

Immune Response Mechanisms against AAV Vectors in Animal Models
por: Martino, Ashley T., et al.
Publicado: (2019)

Development of gene transfer for induction of antigen-specific tolerance
por: Sack, Brandon K, et al.
Publicado: (2014)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023)

Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
por: Lam, Anh K., et al.
Publicado: (2022)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa
por: Nichols, Timothy C., et al.
Publicado: (2020)

Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

The hunt for novel AAV capsids with improved cardiac tropism
por: Miguel-dos-Santos, Rodrigo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8mqqhcv45ejiq2rj3ih4r8iem